This mdr is created as a follow-up to record (b)(4), initially reported on product code oto asr exemption # e2014015 for february-march 2017.This mdr is to reflect the additional information to be added to the initial asr report.Additional information reported to coloplast though not verified, indicated discomfort, burning/pain, neuralgia, bloody discharge, granulation tissue at the left vaginal cuff and atrophic/inflamed vaginal mucosa, mild urinary frequency, mesh erosion.On (b)(6) 2015 - excision of vaginal mesh, revision of vaginal cuff an cystourethroscopy.On (b)(6) 2015 - multiple uti's with hematuria.On (b)(6) 2019 - bothersome recurrent mesh erosion.On (b)(6) 2019 - excision of vaginal mesh and cystourethroscopy.
|